Tobacco Use: Clinical Trials

30 trials for Tobacco Use, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

18 completed, 5 unknown, 3 recruiting, 2 active not recruiting. 30 Phase 3, 8 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 330Completed 18, Unknown 5, Recruiting 3, Active not recruiting 2, Not yet recruiting 1, Terminated 1
Phase 28Completed 6, Terminated 1, Unknown 1

Follow Tobacco Use: new trials by email Literature Review of Tobacco Use trials Research Report on Tobacco Use

Trials (filtered) newest first · largest first

All 30 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Optimizing Treatment of Co-occurring Smoking and Unhealthy Alcohol Use Among PWH in Nairobi, Kenya
Cystine, Positively Smoke Free, Placebo - HIV, Tobacco Use
Phase 3Not yet recruitingUniversity of Chicago3002026-07-312026-07-30
Intervention to Increase Intention to Change Alcohol/Tobacco Use in Veterans With Chronic Disease
MINDSET, Usual Care - Tobacco Smoking, Alcohol-Related Disorders
Phase 3RecruitingVA Office of Research and Development2702025-10-012025-12-31
V+PSF-M for Tobacco Cessation in HIV Care in India
Varenicline, Positively Smoke Free Mobile (PSF-M), Standard Care - Human Immunodeficiency Virus, Smoking Cessation
Phase 3RecruitingUniversity of Colorado, Denver4002024-01-022025-06-15
Motivational Interviewing and Mindfulness-Oriented Recovery Enhancement
MORE and MI and NRT, MORE and No MI and NRT, Support Group and MI and NRT - Polysubstance Abuse, Opioid Use
Phase 3RecruitingRutgers, The State University of New Jersey4202023-09-052026-07-17
Optimizing Tobacco Use Treatment for PLWHA
Varenicline, Nicotine patch, Standard treatment - HIV/AIDS, Nicotine Dependence
Phase 3Active not recruitingAbramson Cancer Center at Penn Medicine3402020-02-172026-09-04
COMET2 Project 1 Filter Ventilation Study
Ventilated cigarettes only, Unventilated cigarettes only, Access to Experimental Marketplace: Ventilated cigarettes + alternative nicotine delivery systems - Smoking, Tobacco Use
Phase 3CompletedMasonic Cancer Center, University of Minnesota1182018-10-182022-04-29
Randomized Trial of Electronic Cigarettes With or Without Nicotine in Smoking Cessation.
Electronic cigarette without nicotine (ECwN) plus active varenicline tablets, Electronic cigarette without nicotine (ECwoN) plus placebo tablets of varenicline, Electronic cigarette with nicotine (ECwN) plus placebo tablets of varenicline - Smoking Cessation, Smoking, Cigarette
Phase 3Active not recruitingAssistance Publique - Hôpitaux de Paris6502018-10-172025-12-29
Curcumin; Rose Bengal; Denture Stomatitis
Curcumin, Rose Bengal, Nystatin - Candida Albicans Infection, Cigarette Smoking
Phase 3UnknownKing Saud University452018-07-032021-04-08
Impact of Very Low Nicotine Content Cigarettes in a Complex Marketplace
Very Low Nicotine Content Cigarettes, Normal Nicotine Content Cigarettes - Tobacco Smoking, Nicotine Dependence
Phase 3CompletedUniversity of Minnesota7992018-06-012024-08-20
EVarQuit: Extended Pre-quit Varenicline to Assist in Quitting Smoking
Varenicline, Brief smoking cessation counseling - Tobacco Smoking
Phase 3CompletedState University of New York at Buffalo3202017-10-012025-09-26
Studying Partial-agonists for Ethanol and Tobacco Elimination in Russians With HIV (St PETER HIV)
Varenicline, Cytisine, Nicotine Replacement Therapy - HIV Infection, Alcohol Use
Phase 2 / Phase 3CompletedBoston Medical Center4002017-07-192020-12-17
The Lung Screening, Tobacco and Health Project
Intensive Telephone Counseling (8 sessions) with nicotine replacement, Usual Care: Telephone counseling (3 sessions) with nicotine replacement - Smoking, Tobacco, Tobacco-Related Carcinoma
Phase 3CompletedGeorgetown University11142017-05-032023-11-02
Pictorial Warning Labels and Memory for Cigarette Health-risk Information Over Time
Text-only PWL, Low-emot PWL, High-emot PWL - Smoking Cessation, Smoking, Cigarette
Phase 3CompletedOhio State University44242015-04-172017-12-18
Dissemination of a Tailored Tobacco Quitline for Rural Veteran Smokers
Nicotine replacement therapy - Transdermal nicotine patch, Nicotine replacement therapy - Nicotine gum, Nicotine replacement therapy - Nicotine lozenge - Nicotine Dependence, Tobacco Use
Phase 3UnknownMark Vander Weg4112013-07-012017-07-11
N-acetylcysteine for Tobacco Smoking
N-acetylcysteine - Tobacco Smoking, Oxidative Stress
Phase 3UnknownUniversidade Estadual de Londrina322013-02-012014-04-28
Tailored Smoking Cessation Treatment for LIVE FOR LIFE® Participants
varenicline (Chantix), bupropion (Zyban), nicotine patches - Cigarette Smoking, Nicotine Dependence
Phase 2 / Phase 3TerminatedDuke University192012-05-012014-12-24
Mechanistic Evaluations of Pre-Cessation Therapies for Smoking Cessation
Varenicline, Bupropion, Nicotine patches - Nicotine Dependence
Phase 3CompletedDuke University2822011-07-012017-11-14
Concurrent Bupropion / Varenicline for Smoking Cessation
Varenicline, Bupropion, Nicotine patches - Nicotine Dependence
Phase 3CompletedDuke University7022011-03-012014-08-06
Testing Counseling Styles to Motivate Smokers to Quit
Brief Advice (BA), Motivational Interviewing (MI), Health Education (HE) - Smoking, Tobacco Use
Phase 3CompletedUniversity of Missouri, Kansas City2552010-10-012012-07-04
Highdose Nicotine Patch Therapy for Smokeless Tobacco Use
nicotine replacement therapy (nicotine patches), placebo NRT - Smokeless Tobacco Use
Phase 2 / Phase 3CompletedMayo Clinic522010-07-012014-05-19

Showing 20 of 30. Sign in to see all of them.

Narrower conditions

Smoking Cessation (12)  ·  Tobacco Use Disorder (12)  ·  Cigarette Smoking (11)  ·  Tobacco Smoking (7)  ·  Smoking (5)  ·  Alcohol Drinking (3)  ·  Tobacco Use Cessation (3)  ·  Acquired Immunodeficiency Syndrome (2)  ·  Inflammation (2)  ·  Alcohol-Related Disorders (1)  ·  Alcoholism (1)  ·  Behavior (1)  ·  Body Weight (1)  ·  Chronic Disease (1)

Broader conditions

Behavior (29)  ·  Smoking (15)  ·  Chemically-Induced Disorders (14)  ·  Health Behavior (14)  ·  Mental Disorders (14)  ·  Substance-Related Disorders (14)  ·  Tobacco Smoking (11)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Blood-Borne Infections (3)  ·  Communicable Diseases (3)  ·  Drinking Behavior (3)  ·  Genital Diseases (3)  ·  Immune System Diseases (3)  ·  Immunologic Deficiency Syndromes (3)

Interventions

Varenicline (9)  ·  Tobacco Use Cessation Devices (8)  ·  Bupropion (4)  ·  Nicotine (4)  ·  Nicotine Replacement Therapy (3)  ·  Standard of Care (3)  ·  Motivational Interviewing (2)  ·  3-azido-2,7-naphthalene disulfonate (1)  ·  Acetylcysteine (1)  ·  Counseling (1)  ·  Crisis Intervention (1)  ·  Curcumin (1)  ·  Cystine (1)  ·  Educational Status (1)  ·  Electronic Nicotine Delivery Systems (1)

Sponsors

Duke University (4)  ·  Mayo Clinic (4)  ·  Abramson Cancer Center at Penn Medicine (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Boston Medical Center (1)  ·  Georgetown University (1)  ·  Kaiser Permanente (1)  ·  Karolinska Institutet (1)  ·  King Saud University (1)  ·  Mark Vander Weg (1)  ·  Masonic Cancer Center, University of Minnesota (1)  ·  Ohio State University (1)  ·  Rutgers, The State University of New Jersey (1)  ·  State University of New York at Buffalo (1)  ·  Tata Memorial Hospital (1)

Countries

United States (21)  ·  India (2)  ·  Brazil (1)  ·  Denmark (1)  ·  France (1)  ·  Kenya (1)  ·  Russia (1)  ·  Saudi Arabia (1)  ·  Sweden (1)

Top investigators

Jed E Rose, Ph.D. (3)  ·  Jon O Ebbert, MD (2)  ·  Amit Sood, M.D. (1)  ·  Asgeir R Helgason, PhD (1)  ·  Delwyn Catley, Ph.D. (1)  ·  Dorothy Hatsukami, PHD (1)  ·  Dorothy K Hatsukami, Ph.D (1)  ·  F. Joseph McClernon, Ph.D. (1)  ·  Gina Kruse, MD (1)  ·  Jack F Hollis, Ph.D. (1)  ·  Jeffrey H Samet, MA, MA, MPH (1)  ·  Jennifer S Funderburk, PhD (1)  ·  Julie Christina Gass, PhD (1)  ·  Lars Forsberg, PhD (1)  ·  Lori Pbert, PhD (1)

Results publications

PMID 37142273, PMID 17852172, PMID 18608316, PMID 20379614, PMID 20811658, PMID 22007015, PMID 22713093, PMID 23454876, PMID 23873976, PMID 24934962, PMID 26711164, PMID 27081187, PMID 29895280, PMID 29947729, PMID 31129603, PMID 31466882, PMID 33219852, PMID 33868901, PMID 33878020, PMID 33964415, PMID 34077535, PMID 34611902, PMID 35143041, PMID 35448154, PMID 35818122, PMID 35818125, PMID 35906990, PMID 35930287, PMID 36367720, PMID 37230961, PMID 37347538, PMID 38911348, PMID 40701191, PMID 40720285, PMID 41352530, PMID 41852246

NIH funding

P50DA027840 (2), 2005 (1), 2017 (1), P50CA180908 (1), R01CA098685 (1), R01CA133068 (1), R01CA206193 (1), R01CA207228 (1), R01CA243914 (1), R01CA288235 (1), R01DA057631 (1), U01AA020780 (1), U01CA261614 (1)